(Q37276787)

English

Does C-reactive protein predict the long-term progression of interstitial lung disease and survival in patients with early systemic sclerosis?

scientific article published on August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Does C-reactive protein predict the long-term progression of interstitial lung disease and survival in patients with early systemic sclerosis? (English)

1 reference

Europe PubMed Central

19 August 2017

interstitial lung disease

1 reference

based on heuristic

inferred from title

John D Reveille

7

object named as

John D Reveille

1 reference

Europe PubMed Central

19 August 2017

author name string

Xiaochun Liu

1

1 reference

Europe PubMed Central

19 August 2017

Maureen D Mayes

2

1 reference

Europe PubMed Central

19 August 2017

Claudia Pedroza

3

1 reference

Europe PubMed Central

19 August 2017

Hilda T Draeger

4

1 reference

Europe PubMed Central

19 August 2017

Emilio B Gonzalez

5

1 reference

Europe PubMed Central

19 August 2017

Brock E Harper

6

1 reference

Europe PubMed Central

19 August 2017

Shervin Assassi

8

1 reference

Europe PubMed Central

19 August 2017

publication date

1 August 2013

1 reference

Europe PubMed Central

19 August 2017

Arthritis Care and Research

1 reference

Europe PubMed Central

19 August 2017

65

1 reference

Europe PubMed Central

19 August 2017

8

1 reference

Europe PubMed Central

19 August 2017

1375-1380

1 reference

Europe PubMed Central

19 August 2017

Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816494

6 September 2017

Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816494

6 September 2017

Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816494

6 September 2017

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816494

6 September 2017

Systemic sclerosis - continuing progress in developing clinical measures of response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816494

6 September 2017

C-reactive protein, inflammation, and innate immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816494

6 September 2017

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816494

6 September 2017

Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816494

3 September 2018

Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816494

3 September 2018

Serum interleukin-6 level is reflected in elevated high-sensitivity C-reactive protein level in patients with systemic sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816494

3 September 2018

Relation between elevated high-sensitivity C-reactive protein and anti-mitochondria antibody in patients with systemic sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816494

3 September 2018

Severe restrictive lung disease in systemic sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816494

3 September 2018

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1002%2FACR.21968

21 January 2018

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

1 reference

https://api.crossref.org/works/10.1002%2FACR.21968

21 January 2018

A disease severity scale for systemic sclerosis: development and testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/23401350

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased levels of amino terminal propeptide of type III procollagen are an unfavourable predictor of survival in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23401350

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ACR.21968

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37276787&oldid=2153373523"